Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-06 Gray Nancy Ryan Director Grant or award +835 2,241
2019-06-06 Gray Nancy Ryan Director Grant or award · Non-Qualified Stock Option (right to buy) +4,071 4,071
2019-06-06 KOZARICH JOHN W Director Grant or award +835 26,377
2019-06-06 KOZARICH JOHN W Director Grant or award · Non-Qualified Stock Option (right to buy) +4,071 4,071
2019-06-06 LAMATTINA JOHN L Director Grant or award +835 22,284
2019-06-06 LAMATTINA JOHN L Director Grant or award · Non-Qualified Stock Option (right to buy) +4,071 4,071
2019-06-06 Patel Sunil Director Grant or award +835 25,359
2019-06-06 Patel Sunil Director Grant or award · Non-Qualified Stock Option (right to buy) +4,071 4,071
2019-05-31 HIGGINS JOHN L Chief Executive Officer Purchase +1,000 $108.20 $108K 144,899
2019-05-31 Aryeh Jason Director Purchase +500 $108.51 $54K 60,618
2019-05-30 Aryeh Jason Director Purchase +250 $110.01 $28K 60,118
2019-05-29 Aryeh Jason Director Purchase +250 $111.01 $28K 59,868
2019-05-20 Aryeh Jason Director Purchase +250 $112.01 $28K 59,618
2019-05-14 Aryeh Jason Director Purchase +250 $112.51 $28K 59,368
2019-05-14 HIGGINS JOHN L Chief Executive Officer Purchase +2,500 $113.50 $284K 143,899
2019-05-14 KOZARICH JOHN W Director Option exercise +2,500 $17.88 $45K 28,042
2019-05-14 KOZARICH JOHN W Director Sale −2,500 $112.92 $282K 25,542
2019-05-14 KOZARICH JOHN W Director Option exercise · Non-Qualified Stock Option (right to buy) −2,500 0
2019-03-14 FOEHR MATTHEW W President and COO Option exercise +14,894 $9.97 $148K 140,447
2019-03-14 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −14,894 15,001

Page 44 of 55 · 1,097 trades